5–6/12/2025
Divani Caravel Hotel/ Athens.
IASIS PHARMA participated in the 11th Panhellenic Conference of Working Groups organized by the Hellenic Atherosclerosis Society. The conference was held from 05 to 06/12/2025, at the Divani Caravel Hotel in Athens, with the participation of many Healthcare Professionals.
Participants had the opportunity to learn more about the high-quality pharmaceutical products available from the company.
At IASIS PHARMA exhibition stand, the following products were displayed:
- RosuZet®: Fixed-dose combination of Rosuvastatin & Ezetimibe, in a single dosage form, in packages of 30 f.c. tabs available in the full spectrum of strengths:5/10mg, 10/10mg, 20/10mg and 40/10mg.
- Rami–Amlo®: a fixed-dose combination of Ramipril & Amlodipine in a single dosage form, in packages of 28 capsules, available in 4 strengths:
5mg/5mg,
5mg/10mg,
10mg/5mg,
10mg/10mg. - Rami–Amlo plus®, also an original fixed-dose combination of Ramipril – Amlodipine –Hydrochlorothiazide, which is available in packages of 30 capsules, in a wide range of strengths: 5mg/5mg/12,5 mg, 5 mg/5 mg/25 mg, 10 mg/5 mg/25 mg, 10 mg/10 mg/25 mg.


